IRIS publication 379685
6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.
RIS format for Endnote and similar
TY - CONF - Harris, D.M., Fisher, A., Mandel, A., Bolton, A.E., Sullivan, A.M., Nolan, Y. - International Congress on Parkinson’s Disease and Related Disorders, Berlin, Germany. - 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation. - Berlin, Germany - Invited Lectures (Conference) - 2005 - () - 1 - 05-JUN-05 - 08-JUN-06 - Vasogen Ireland Limited DA - 2005/NaN ER -
BIBTeX format for JabRef and similar
@unpublished{V379685, = {Harris, D.M. and Fisher, A. and Mandel, A. and Bolton, A.E. and Sullivan, A.M. and Nolan, Y. }, = {International Congress on Parkinson’s Disease and Related Disorders, Berlin, Germany.}, = {{6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.}}, = {Berlin, Germany}, = {Invited Lectures (Conference)}, = {2005}, = {()}, = {1}, month = {Jun}, = {08-JUN-06}, = {Vasogen Ireland Limited}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Harris, D.M., Fisher, A., Mandel, A., Bolton, A.E., Sullivan, A.M., Nolan, Y. | ||
TITLE | International Congress on Parkinson’s Disease and Related Disorders, Berlin, Germany. | ||
PUBLICATION_NAME | 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation. | ||
LOCATION | Berlin, Germany | ||
CONFERENCE_TYPE | Invited Lectures (Conference) | ||
YEAR | 2005 | ||
TIMES_CITED | () | ||
PEER_REVIEW | 1 | ||
START_DATE | 05-JUN-05 | ||
END_DATE | 08-JUN-06 | ||
ABSTRACT | |||
FUNDED_BY | Vasogen Ireland Limited |